A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Study Type
OBSERVATIONAL
Enrollment
200
cerebral artery dilation device
Improvement in target vessel diameter following NeVa VS use
Time frame: Up to 1 hour post procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.